Disclosing Recovery: A pilot randomized controlled trial of a patient decision aid to improve disclosure processes for people in treatment for opioid use disorder

• Published in: Journal of substance use and addiction treatment Vol. 160; p. 209291
• Main Authors: Earnshaw, Valerie A., Sepucha, Karen R., Laurenceau, Jean-Philippe, Subramanian, S.V., Hill, E. Carly, Wallace, James, Brousseau, Natalie M., Henderson, Claire, Brohan, Elaine, Morrison, Lynn M., Kelly, John F.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2024
• Subjects: Adult; Decision Making; Decision Support Techniques; Disclosure; Female; Humans; Male; Middle Aged; Opioid use disorder; Opioid-Related Disorders - psychology; Opioid-Related Disorders - therapy; Patient decision aid; Pilot Projects; Randomized controlled trial; Patient decision aid; Disclosure; Opioid use disorder; Randomized controlled trial
• ISSN: 2949-8759; 2949-8759
• DOI: 10.1016/j.josat.2024.209291

People engaged in treatment for opioid use disorder (OUD) report struggling with whether and how to disclose, or share information about their OUD history and/or treatment with others. Yet, disclosure can act as a gateway to re-establishing social connection and support during recovery. The current study describes a pilot randomized controlled trial of Disclosing Recovery: A Decision Aid and Toolkit, a patient decision aid designed to facilitate disclosure decisions and build disclosure skills. Participants (n = 50) were recruited from a community-based behavioral health organization in 2021–2022 and randomized to receive the Disclosing Recovery intervention versus an attention-control comparator. They responded to surveys immediately after receiving the intervention as well as one month following the intervention at a follow-up appointment. Primary outcome analyses examined indicators of implementation of the intervention to inform a future efficacy trial. Secondary outcome analyses explored impacts of the intervention on the decision-making process, disclosure rates, and relationships. Participants were successfully recruited, randomized, and retained, increasing confidence in the feasibility of future efficacy trials to test the Disclosing Recovery intervention. Moreover, participants in the Disclosing Recovery intervention agreed that the intervention is acceptable, feasible, and appropriate. They additionally reported a higher quality of their decision-making process and decisions than participants in the comparator condition. At their follow-up appointment, participants with illicit opioid use who received the Disclosing Recovery intervention were less likely to disclose than those who received the comparator condition. Moreover, significant interactions between illicit opioid use and the intervention condition indicated that participants without illicit opioid use who received the Disclosing Recovery intervention reported greater closeness to and social support from their planned disclosure recipient than those who received the comparator condition. The Disclosing Recovery intervention appears to be an acceptable, feasible, and appropriate patient decision aid for addressing disclosure processes among people in treatment for OUD. Moreover, preliminary results suggest that it shows promise in improving relationship closeness and social support in patients without illicit opioid use. More testing is merited to determine the intervention's efficacy and effectiveness in improving relationship and treatment outcomes for people in treatment for OUD. •People in opioid use disorder (OUD) treatment struggle with disclosure decisions.•Disclosing Recovery is a patient decision aid for disclosure decisions and skills.•It appears to be acceptable, appropriate, and feasible.•Future trials should examine its impacts on relationship and treatment outcomes.